Walleye Trading LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $746,956 - $1.07 Million	25,900 Added 95.93%	52,900 $1.53 Million
Q2 2024 Aug 14, 2024	SELL	$38.07 - $59.71 $433,998 - $680,694	-11,400 Reduced 29.69%	27,000 $1.04 Million
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $465,276 - $608,748	8,400 Added 28.0%	38,400 $2.26 Million
Q4 2023 Feb 14, 2024	SELL	$37.14 - $64.82 $880,218 - $1.54 Million	-23,700 Reduced 44.13%	30,000 $1.8 Million
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $898,700 - $3.39 Million	38,000 Added 242.04%	53,700 $2.04 Million
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $253,044 - $307,923	3,300 Added 26.61%	15,700 $1.43 Million
Q1 2023 May 15, 2023	SELL	$46.59 - $66.96 $1.53 Million - $2.2 Million	-32,800 Reduced 72.57%	12,400 $817,000
Q4 2022 Feb 14, 2023	BUY	$43.24 - $61.04 $773,996 - $1.09 Million	17,900 Added 65.57%	45,200 $2.34 Million
Q3 2022 Nov 14, 2022	SELL	$44.76 - $69.66 $550,548 - $856,818	-12,300 Reduced 31.06%	27,300 $1.87 Million
Q2 2022 Aug 08, 2022	BUY	$35.07 - $59.21 $1.03 Million - $1.73 Million	29,300 Added 284.47%	39,600 $1.79 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $365,238 - $557,436	10,300 New	10,300 $523,000
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $636,318 - $1.02 Million	-20,700 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $423,900 - $942,840	13,500 Added 187.5%	20,700 $682,000
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $294,480 - $467,280	7,200 New	7,200 $455,000
Q3 2020 Nov 16, 2020	SELL	$25.89 - $33.65 $478,965 - $622,525	-18,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$24.8 - $38.49 $178,560 - $277,128	7,200 Added 63.72%	18,500 $604,000
Q1 2020 May 15, 2020	SELL	$17.91 - $44.33 $84,177 - $208,351	-4,700 Reduced 29.38%	11,300 $303,000
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $353,600 - $492,800	16,000 New	16,000 $490,000

Others Institutions Holding APLS

# of Institutions

308

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

Wellington Management Group LLP Boston, MA

15.6M
Shares

$516 Million
0.08% of portfolio
Eco R1 Capital, LLC San Francisco, CA

11.9M
Shares

$394 Million
14.88% of portfolio
Avoro Capital Advisors LLC New York, NY

11.1M
Shares

$368 Million
4.82% of portfolio
Vanguard Group Inc Valley Forge, PA

9.82M
Shares

$325 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.8M
Shares

$192 Million
0.01% of portfolio

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.64B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account